Status:
COMPLETED
Retrospective Study: Long-term Health of Living Kidney Donors
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
National Kidney Foundation, United States
Conditions:
Kidney Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Kidney transplantation, is the preferred treatment option of end stage renal disease. Compared to dialysis, patients who receive kidneys have a 70% reduction in death, a dramatically improved quality ...
Eligibility Criteria
Inclusion
- Age greater than 18 years old
- Living kidney transplant occurred between 1970 and 2006
- no history of hypertension, kidney disease or proteinuria prior to donation
Exclusion
- a medical condition (such as cardiovascular disease, pulmonary disease, or active cancer) which makes one ineligible to be a donor. Blood group and immunological incompatibility (such as positive cross-match, poor HLA matches) are not reasons for exclusion.
- The eligible non-donor subsequently went on to donate a kidney
- Either the donor or the eligible non-donor are unable to give informed consent
- The living donor or eligible non-donor is currently pregnant
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT00319527
Start Date
May 1 2004
End Date
March 1 2008
Last Update
February 26 2024
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia, 6009
2
University of Alberta
Edmonton, Alberta, Canada, T6G 2G3
3
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
4
Dalhousie University
Halifax, Nova Scotia, Canada, B3H 1V8